微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Fulcrum Therapeutics (NASDAQ:FULC) +125%
Exagen (NASDAQ:XGN) +24%
Myomo (NYSE:MYO) +16%
IMV (NASDAQ:IMV) +8%
Allied Healthcare Products (NASDAQ:AHPI) +6%
Losers:...查看全文
格隆汇3月14日丨Myomo(MYO.US)盘前继续上涨8.44%,报0.835美元,该股月内累计涨幅近20%,且昨日涨4%创阶段新高。公司2022年Q4财报实现营收404.2万美元,前值为403.2万美元,预期值为406万美元;每... 网页链接
$Myomo(MYO)$ FWP Filing under Securities Act Rules 163/433 of free writing prospectuses Accession Number: 0001193125-20-026794 Act: 34 Size: 18 KB 网页链接
$Myomo(MYO)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001193125-20-022213 Act: 33 Size: 8 MB 网页链接
$Myomo(MYO)$ FWP Filing under Securities Act Rules 163/433 of free writing prospectuses Accession Number: 0001193125-20-022216 Act: 34 Size: 12 MB 网页链接
$Myomo(MYO)$ 8-K Current report, items 5.03, 5.07, and 9.01 Accession Number: 0001193125-20-019589 Act: 34 Size: 37 KB 网页链接
$Myomo(MYO)$ 8-K Current report, items 5.07 and 8.01 Accession Number: 0001193125-20-011007 Act: 34 Size: 18 KB 网页链接
$Myomo(MYO)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-20-007598 Act: 34 Size: 26 KB 网页链接
$Myomo(MYO)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001193125-20-007317 Act: 33 Size: 7 MB 网页链接
$Myomo(MYO)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-20-000650 Act: 34 Size: 494 KB 网页链接
$Myomo(MYO)$ PRE 14A Other preliminary proxy statements Accession Number: 0001193125-19-322645 Act: 34 Size: 492 KB 网页链接
$Myomo(MYO)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001193125-19-317530 Act: 34 Size: 27 KB 网页链接